How TrumpRx Brand-Name Drug Prices Compare to Other Countries

TrumpRx prices for brand-name drugs are about as likely to be higher as lower compared to average prices in other wealthy countries, according to an analysis that compares 32 brand-name drugs (without generics or biosimilars) on the TrumpRx website with publicly available prices in one or more of 11 OECD member countries: Australia, Austria, Belgium, Canada, France, Germany, Japan, the Netherlands, Sweden, Switzerland, and the United Kingdom.

For 17 of the 32 drugs, the TrumpRx price is lower than the average price in comparable countries. This includes five drugs for which the TrumpRx price is lower than the prices available in any of the other countries. Eight drugs have a price that is $100 less than the average in other countries. For the other 15 drugs, the TrumpRx price is higher than the average price in comparable countries. This includes 13 drugs for which the TrumpRx price is higher than prices available in any of the other countries.

The full analysis and other data on health costs are available on the Peterson-KFF Health System Tracker, an online information hub dedicated to monitoring and assessing the performance of the U.S. health system.